We have previously shown that BTG1 stimulates myoblast dierentiation. In addition, this protein displays a major nuclear localization in con¯uent myoblasts, decreasing during the early steps of dierentiation, and is essentially detected in the cytoplasm of mature myotubes. To identify the domains involved in the cellular tracking of BTG1, we observed the localization of several BTG1 sequences fused to bGalactosidase. The highly conserved B box among all members of the BTG family induces a signi®cant nuclear localization of the bGal moiety, enhanced by presence of the BTG1 carboxy-terminal sequence. In addition, a functional Nuclear Export Signal (NES) overlaps the B box. Moreover, presence of the ®rst 43 NH 2 -terminal amino acids reduced the nuclear localization of each chimeric protein tested. Last, the BTG1 amino-terminal domain bears an LxxLL motif favouring nuclear accumulation, and another region encompassing the A box inhibiting nuclear localization. In contrast to a BTG1 mutant exclusively localized in the cytoplasm, transient expression of a mutant displaying a nuclear localization enhanced myoblasts withdrawal from the cell cycle and terminal dierentiation, thus mimicking the myogenic in¯uence of BTG1. In conclusion, several regions of BTG1 are implicated in its cellular localization, and BTG1 myogenic activity is induced at the nuclear level.
Introduction
The btg1 (B-cell Translocation Gene 1) gene coding sequence was isolated from a translocation break point t(8; 12) (q24; q22) in a case of B-cell Chronic Lymphocytic Leukaemia (CLL-B) (Rimokh et al., 1991; Rouault et al., 1992) and shared high homology with the previously identi®ed tis21 (Fletcher et al., 1991) and pc3 (Bradbury et al., 1991) genes. To date, seven genes have been classi®ed in the same family on the basis of their sequence homology (GueÂ henneux et al., 1997) . Their predicted peptidic sequence displays a high degree of conservation in two regions of 22 and 20 amino acids named boxes A and B (GueÂ henneux et al., 1997) which constitute the two signature motifs of this family.
A previous study demonstrated that BTG1 expression is easily detected in quiescent adult tissue (Rouault et al., 1992) . In agreement with this observation, BTG1 mRNA is preferentially induced at the G0/G1 phase transition of the cell cycle (Rouault et al., 1992) and decreases as the cells progress throughout G1. Moreover BTG1 and its related proteins inhibit proliferation of several cell lines including NIH3T3, PC12 and QM7 quail myoblast lines (Rouault et al., 1992; Montagnoli et al., 1996; Matsuda et al., 1996; Rodier et al., 1999) . Therefore, it is believed that these proteins are members of an antiproliferative protein family.
However, their molecular role is poorly understood. The previous observation that Tob (Transducer Of erbB-2) interacts with the membrane-bound growth factor receptor erbB2 suggests that it could be involved in growth factor-signalling pathway (Matsuda et al., 1996) . More recent studies using a system of two hybrid interactions demonstrated that BTG1 and BTG2 (Tis21/PC3) interact with other proteins. First, Herschman's group reported an interaction with PRMT1 (Protein-Arginin N-MethylTransferase) (Lin et al., 1996) , which asymmetrically methylates arginine residues occurring in the glycine-and arginine-rich domain (RGG) of hnRNP substrates (Rajpurohit et al., 1994) or histones (Ghosh et al., 1988) . Furthermore, by using CARM1, homologous to protein arginine methyltransferase PRMT1, Chen et al. (1999) demonstrated that arginine methylation contributes to transcriptional regulation. Other interactions have been subsequently reported with CAF1 (Rouault et al., 1998; Bogdan et al., 1998) and the homeoprotein Hoxb9 (Prevot et al., 2000) . CAF1 is the murine homologue of a yeast component of the CCR4 transcriptional regulatory system (Draper et al., 1995) interacting with BTG1 and BTG2 through the B box (Rouault et al., 1998) . More recently, Ikematsu et al. (1999) described such an interaction between Tob2 and the human homologue of CAF1, stressing a possible functional importance of this association for BTG family proteins. In agreement Figure 1 The B box and the carboxy terminus domain of BTG1 are involved in the nuclear localization of the protein. Cells were transiently transfected with the vector pCH110 encoding the wild type bGalactosidase (a); or encoding the following sequences fused to bGal: box B, B/bGal (b); full length BTG1, BTG1/bGal (c); BTG1 without the B box, BTG1DB/bGal (d); B box and the carboxy-terminal region of BTG1, B-C-ter/bGal (e); carboxy-terminal domain of BTG1 (aa: 119 ± 171), C-ter/bGal (f); B box and
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A Rodier et al with these data suggesting that a part of their antiproliferative activity involves the control of gene expression, Guardavaccaro et al. (2000) reported that cyclin D1 transcription is decreased by BTG2 expression, leading to the accumulation of the hypophosphorylated, growth inhibitory forms of pRb. In addition, it has been shown that CAF1 is capable of binding cyclin-dependent kinases (Ikematsu et al., 1999) . In previous works (Marchal et al., 1995; Rodier et al., 1999) we demonstrated that the BTG1 protein is located in the nucleus of con¯uent QM7 avian myoblasts. Its nuclear accumulation was increased by the presence of triiodothyronine (T3) or 8-Br-cAMP which also reduced proliferation and stimulated dierentiation in this cell line (Marchal et al., 1993 (Marchal et al., , 1995 . Interestingly, we also observed that the nuclear localization of BTG1 displays a transient feature since in the early dierentiation steps, amounts of the protein decrease in the nucleus and BTG1 becomes essentially located in the cytoplasm of mature myotubes (Rodier et al., 1999) . This cellular tracking is probably associated with substantial changes in the activity of the protein.
The major aim of this study was to identify BTG1 sequences involved in the cellular tracking of the protein, using chimeric constructs composed of BTG1 domains fused to the bGalactosidase enzyme. We ®rst observed that BTG1 does not bear any Nuclear Localization Sequence (NLS) similar to that previously identi®ed on SV40TAg (Newmeyer and Forbes, 1988) or nucleoplasmin (Dingwall et al., 1982) and we found that several sequences are speci®cally involved in the determination of each BTG1 cellular localization. We concluded that the B box is sucient to drive signi®cant amounts of bGal in the nucleus, and that its in¯uence is strongly increased in the presence of the BTG1 carboxyterminal domain. Moreover, we identi®ed a functional Nuclear Export Signal (NES) overlapping the B box, closely related to that described in the viral Rev protein (Fischer et al., 1995) , cellular protein PKI (Wen et al., 1995) or MAPKK (Fukuda et al., 1996) . In addition, 43 residues of BTG1 amino-terminus inhibit the nuclear accumulation of several chimeric proteins. We also characterized two other domains of this amino-terminal region involved in BTG1 cellular localization: an LxxLL motif favouring nuclear accumulation, and a region encompassing the A box involved in the cytoplasmic localization of the protein. Last, we observed that a BTG1 mutant displaying an exclusive nuclear localization enhances myoblast withdrawal from the cell cycle and their terminal dierentiation, whereas a cytoplasmic mutant was devoid of any myogenic activity. These data suggest that regulation of BTG1 cellular tracking partly drives its in¯uence on myoblast dierentiation.
Results
The B box and the carboxy terminus domain are involved in the nuclear localization of BTG1
The well-conserved B box has been shown to mediate the interaction of BTG1 with the nuclear protein CAF1 in yeast (Rouault et al., 1998) . This result raised the question of a possible involvement of this domain in the nuclear localization of BTG1. To test this hypothesis, we expressed a B box/bGal fusion protein in QM7 cells. Whereas bGal alone was detected in the nuclei of a reduced number of transfected cells (percentage of cells harbouring exclusive nuclear staining N+percentage of cells harbouring simultaneous nuclear and cytoplasmic staining N/C=N+N/ C: 7%; Figure 1a ), the B box drove signi®cant amounts of this protein into the nuclei, re¯ected by an 11.5-fold increase in the number of cells displaying nuclear staining (N+N/C: 81%, P50.001; Figure 1b) . Conversely, deletion of the B box in the BTG1 integral protein fused to bGal fully abrogated its nuclear localization (N+N/C: 0% vs 11% for BTG1/bGal, P50.001; Figure 1d and c respectively).
In addition, although it was unable to aect by itself the cell localization of the bGal moiety (Figure 1f ), the presence of the BTG1 carboxy-terminal strongly potentiated the frequency of nuclear staining induced by the B box (Figure 1e ). Not only was bGal detected in the nuclei of all cells (N+N/C: 100% vs 81% for B box/bGal, P50.05; Figure 1e and b respectively), but in majority they displayed an exclusive nuclear staining (N: 76% vs 4% for B box/ûGal, P50.001; Figure 1e and b respectively), thus underlining a major in¯uence of this sequence.
These data clearly suggested the involvement of a cooperation between the B box and the carboxy terminal domain in the nuclear localization of BTG1. In a recent study, Bogdan et al. (1998) found that the ability of BTG1 to interact with CAF1 depended on the integrity of p34 cdk2 phosphorylation site (Ser 159) identi®ed in the carboxy-terminal domain of the protein. Similarly, we found that disruption of this the carboxy-terminal region of BTG1 in which serine 159 was replaced by a glycine, B-CterS159G/bGal (g). Cells were submitted to immuno¯uorescence studies using an antibody raised against b-Gal and counted according to the cell localization of the bGal proteins. The percentage of cells that displayed exclusive bGal nuclear staining is expressed relatively to the total number of cells that displayed staining for the bGal (N). The percentage of cells that displayed bGal simultaneous nuclear and cytoplasmic staining is expressed relatively to the total number of cells that displayed staining for the bGal (N/C). The percentage of cells that displayed exclusive bGal cytoplasmic staining is expressed relatively to the total number of cells that displayed staining for the bGal (C). More than 100 cells positive for bGal were counted for each fusion protein. The results are mean+s.e.m. of ®ve separate experiments (n=5). (6400) phosphorylation site by a glycine substitution to serine 159 signi®cantly decreased the number of cells displaying an exclusive nuclear staining (N: 46% vs 76% for B box/C-ter/bGal, P50.001; Figure 1g and e respectively) without altering the detection frequency of a nuclear localization (100% for the two constructs). Guiochon-Mantel et al. (1994) have previously reported that, besides inducing an energy-dependent nuclear translocation, a classical Nuclear Localisation Signal (NLS) sequence could also mediate a passive nuclear protein export. To compare the functionality of the B box with that of a classical NLS, we studied the cell localization of the B box/ûGal chimeric protein under energy deprivation induced by sodium azide or incubation of the cells at 48C (Figure 2A,B) . In these conditions previously shown to inhibit the active nuclear import of various proteins, we should admit only passive phenomena (Guiochon-Mantel et al., 1994) . In the same conditions, we also assessed the in¯uence of the BTG1 carboxy-terminus. Energy deprivation induced a two-(48C; P50.05; Figure  2Ab ,B) or threefold reduction (sodium azide; P50.05; Figure 2Ac ,B) in the number of cells displaying a nuclear localization of the B box/ûGal protein, thus indicating that the nuclear import mediated by the B box was energy-dependent, whereas the export process was energy-independent. Moreover, in the presence of the BTG1 carboxy-terminus, a majority of cells displayed an exclusive nuclear staining not in¯uenced by energy deprivation (Figure 2Ad ± f,B). This last result indicates that the carboxy-terminal domain abrogates passive export of the B box/ûGal protein by a mechanism independent of energy. An increasing number of proteins has been shown to be exported from the nucleus by the way of an interaction of the Nuclear Export Signal (NES) sequence with CRM1/Exportin 1, a nuclear export receptor belonging to the importin b family (Fornerod et al., 1997; Fukuda et al., 1997; Kudo et al., 1997; Ossareh-Nazari et al., 1997; Stade et al., 1997) . NES identi®ed to date share a characteristic Leucine rich sequence (Hall et al., 1983) shown in Figure 3Aa ,b. Interestingly, we identi®ed on BTG1 one putative NES, overlapping the B box ( Figure 3Ac ). Functionality of this putative NES was established in the following experiments ( Figure 3B ). First, juxtaposition to the B box of the small sequence (amino acids 94 ± 98) restoring the whole NES sequence induced a ®vefold reduction in the number of cells displaying an exclusive nuclear localization of the B box-C-ter/bGal protein (N: 15% vs 76%, P50.001; Figure 3Ba ,b). Second, we studied the in¯uence of Leptomycin B, which abrogates NES functionality by antagonizing its interaction with CRM1 (Wol et al., 1997; Kudo et al., 1998) , upon the cellular localization of the endogenous BTG1. After QM7 cells synchronization in G0/G1 by serum starvation, as expected, BTG1 was essentially detected in the nucleus (Figure 3Cb compared to control non-synchronized Figure 3Ca ); 6 h after the release in G1 of the cells by adding 10% foetal calf serum to the culture medium, BTG1 was clearly exported from the nucleus ( Figure 3Cc) ; however, Leptomycin B fully abrogated this phenomenon ( Figure 3Cd ).
The amino-terminal region impedes nuclear localization of the bGal mutants
During the course of this study, we obtained several data indicating that the BTG1 amino-terminal inhibits the nuclear localization of the chimeric proteins (Figure 4a ± c). First, whereas a low but signi®cant number of cells displayed a nuclear localization of the bGal protein, fusion of the amino-terminal sequence to the enzyme was associated with an exclusive cytoplasmic localization in all transfected cells. In the same way, deletion of this 93 amino acids domain in BTG1/bGal (NES-B-C-ter/bGal) induced an eightfold increase in the frequency of the cells displaying a nuclear staining (N+N/C: 93% vs 11% for BTG1/bGal, P50.001; Figure 3Bb compared to Figure 1c ). These observations led us to search for the BTG1 sequences involved in such a cytoplasmic retention.
A hydrophobic domain (amino acids 8 ± 27) and putative phosphorylation sites for PKC (serine 33) or casein kinase II (serine 43) have been previously mapped in this BTG1 region (Rouault et al., 1992; Figure 5 ). Deletion of the hydrophobic domain (BTG1D1 ± 30/bGal) induced a twofold increase in the number of cells in which the BTG1/bGal protein was located in the nucleus (N+N/C: 25 vs 11% BTG1/ bGal, P50.05; Figures 5a and 1c respectively). Conversely, fusion of the hydrophobic domain to a chimera mostly located in the nucleus (BTG1D1 ± 43/ bGal) induced an exclusive cytoplasmic localization of the new protein (N+N/C: 0% vs 85%, P50.001, Figure 5c ,b), thus indicating a particular importance of this domain. However, comparison of BTG1/bGal and BTG1D30 ± 43bGal suggested that functionality of the hydrophobic domain is clearly inhibited by the sequence 30 ± 43 bearing two putative phosphorylation sites (N+N/C: 11% vs 0%, P50.001, Figures 1c and  5c ). Interestingly, in the absence of the BTG1 hydrophobic sequence, the 30 ± 43 sequence exerted an opposite in¯uence: its deletion in the D1 ± 30 mutant induced a threefold increase in the number of cells displaying a nuclear staining (N+N/C: 85 vs 25%, P50.001, Figure 5a ,b). This result suggests that the domain harbouring two putative phosphorylation sites could also regulate functionality of a downstream BTG1 sequence.
Two additional regions of BTG1 are involved in the cellular localization of the protein
To further extend the mapping of the BTG1 domains involved in its cellular localization, we paid particular attention to the in¯uence of the LQELL sequence (amino acids 44 ± 48) corresponding to the consensus LxxLL motif considered as a domain of interaction with members of the nuclear receptor superfamily (Heery et al., 1997) , and to the sequence encompassing the well-conserved A box.
Observation that deletion of the LQELL sequence induced a sixfold decrease in the frequency of cells displaying a nuclear localization of the BTG1D1 ± 43/ ûGal protein (N+N/C: 15% vs 85%, P50.001; Figure  6a compared to Figure 5b ), strongly suggests that this motif is involved in the nuclear localization of BTG1. This hypothesis is well supported by the additional result that this LxxLL sequence drove signi®cant amounts of bGal into the nucleus (N+N/C: 42% vs 7% for bGal only, P50.001; Figure 6c compared to Figure 1a) .
A further deletion encompassing the A box (BTG1D1 ± 78) induced dramatic changes in the localization of the chimeric protein. All cells displayed a nuclear localization of this mutant (N+N/C: 100% vs 15% for BTG1D1 ± 48/ûGal, P50.001; Figure 6b compared to 6a), thus indicating a strong in¯uence of this sequence upon BTG1 cytoplasmic retention.
The carboxy-terminal part of BTG1 plays an important role in the myogenic activity of the protein
We have previously shown that BTG1 overexpression induces myoblast withdrawal from the cell cycle and stimulates terminal dierentiation. In addition, we have suggested that nuclear localization of this protein is needed for this activity (Rodier et al., 1999) . Characterization of functional domains involved in the cell localization of the protein allowed us to study the Functional domains involved in BTG1 localization A Rodier et al myogenic in¯uence of two BTG1 mutants displaying an essential nuclear or cytoplasmic localization. In QM7 cells we transiently expressed the B box/Cter/bGal mutant displaying a major exclusive nuclear localization, and the N-ter-NES/bGal mutant displaying an exclusive cytoplasmic localization. Cells expressing bGal were used as control.
Interestingly, B box/C-ter/bGal expression induced a signi®cant acceleration of myoblast withdrawal from the cell cycle (P50.001, Table 1 ) assessed by the number of myoblasts expressing connectin, a post-mitotic marker, at cell con¯uence. Consequently, this mutant also signi®cantly stimulated myoblast dierentiation, as indicated by an increase in the value of the fusion index (P50.001, Table 1 ). In addition, expression of the N-ter-NES/bGal mutant did not in¯uence signi®cantly these two myogenic events.
Last, as it has been reported that serine 159 plays a key role in the interaction between BTG1 and CAF 1 (Bogdan et al., 1998) , we studied the myogenic activity of the Bbox-C-ter S159G/bgal mutant. Whereas we found that this protein was detected in the nucleus of almost all cells, its expression did not signi®cantly in¯uence myoblast dierentiation (Table 1) .
This set of data clearly suggests that the B box and C-terminal domains of BTG1 play a major role in the myogenic in¯uence of the protein, and that the nuclear localization of the protein is involved in the stimulation of myoblast dierentiation. In addition, the interaction BTG1/CAF1 is probably an important event able to induce some of these processes.
Discussion
The involvement of members of the BTG family for development and cell dierentiation is clearly appearing. Besides the general antiproliferative activity of this family, Xbtg1 has been implicated in gastrulation movements, and is a target of Xbra and Pintallavis, two genes playing a major role in the early events of Xenopus development (Saka et al., 2000) . In addition, a novel member of the family, FOG3, controls sexual fate in Caenorhabditis elegans germ cells (Chen et al., 2000) . Moreover, it has also been reported that TIS 21 expression identi®es single neuroepithelial cells that switch from proliferative to neuron-generating divisions (Iacopetti et al., 1999) . Similarly, in a previous study, we found that BTG1 is probably implicated in the induction of myogenic dierentiation by increasing myoblast withdrawal from the cell cycle (Rodier et al., 1999) . In this study, we have also provided the ®rst data indicating the occurrence of a BTG1 cellular tracking. Whereas the protein is clearly located in the nucleus at myoblast con¯uence, it gradually reaches cytoplasm during myotube formation and maturation. These observations suggest that BTG1 tracking is probably involved in the regulation of its biological activity. As no data were available on this aspect, we addressed this question by (6400) using transient expression of chimeric proteins including dierent BTG1 domains fused to bGalactosidase. Cytoimmuno¯uorescence studies allowed us to observe the cellular localization of each chimera, and therefore to assess the importance of each domain for BTG1 tracking. This approach could also provide some indications concerning possible functional partners involved in BTG1 function, and the cell compartment involved in the myogenic activity of the protein.
In this study, we found that several domains are involved in the cellular localization of BTG1. Overall, the COOH terminus is essentially involved in nuclear import, export and retention whereas the aminoterminal part appears to play a major role in cytoplasmic retention.
Several domains are involved in the nuclear localization of BTG1 BTG1 nuclear import and retention We ®rst observed that the well-conserved B box of the BTG family members drove signi®cant amounts of the bGal moiety into the nucleus. Its functional role in the context of the integral protein is also suggested by the observation that deletion of this sequence fully abrogated the nuclear localization of the protein fused to bGal. However only 4% of transfected cells displayed an exclusive nuclear localization of the B box/bGal protein, thus suggesting that this sequence could act as a weak NLS. Alternatively, it could be proposed that, although able to support an ecient nuclear import mechanism, the B box is not able, by itself, to maintain bGal in the nucleus, thus inducing a permanent shuttling between cytoplasm and nucleus.
In experiments of energy deprivation, we obtained similar results for B box functionality to those previously reported for classical NLS (Kudo et al., 1997) . In particular, B box is clearly involved in an active nuclear import process inhibited by sodium azide or low temperature. Moreover, the B box/bGal protein, as the NLS of the progesterone receptor fused to bGal (Guiochon-Mantel et al., 1994) , exits the nucleus according to a passive pathway. These Figure 5 The ®rst 43 residues of BTG1 are involved in BTG1 cell localization. Immuno¯uorescence study of the localization of chimera protein containing BTG1 deleted from the ®rst 30 residues encompassing the hydrophobic residues fusioned to bGal, BTG1D1 ± 30/bGal (a), BTG1 deleted from the ®rst 43 residues encompassing the hydrophobic domain and the potential phosphorylation sites domain fusioned to bGal, BTG1D1 ± 43/bGal (b), and BTG1 deleted of the potential phosphorylation site domain fusioned to bGal, BTG1D30 ± 43/bGal (c). Results were assessed by counting positive cells for bGal as described in Figure 1 . The results are presented as the mean+s.e.m. of ®ve separate experiments and cell counting (n=5). (6400) observations, clearly in agreement with the second possibility, explain the simultaneous detection of B box/bGal protein in the cytoplasm and the nuclei of 81% of the transfected cells. In addition, it appears that though B box does not share any sequence homology with previously described NLS, it clearly acts in a similar way than a classical NLS.
Another important result is the in¯uence of the BTG1 carboxy-terminal. Whereas this sequence did not change bGal cellular localization by itself, it induced dramatic changes in B box functionality. Fusion of this domain to the B box abrogated the residual exclusive cytoplasmic localization of B box/ bGal, and conversely resulted in an exclusive nuclear Figure 6 Other amino-terminal domains regulate BTG1 cell localization. Immuno¯uorescence study of BTG1 deleted from the ®rst 48 residues of BTG1 containing the hydrophobic residues, the potential phosphorylation sites, and a LxxLL motif, BTG1D1 ± 48/ bGal (a), BTG1 deleted from the ®rst 78 amino acids encompassing the A box (b). Furthermore, we studied the localization of a fusion protein containing the ®ve residues of the LxxLL motif (LQELL) fusioned to the bGal (c). Results were assessed by counting positive cells for bGal as described in Figure 1 In order to assess the in¯uence of BTG1 cell localization on myoblast withdrawal from the cell cycle and their terminal dierentiation, we tansiently expressed two BTG1 mutants displaying a major nuclear (B box-C-ter/bGal) or an exclusive cytoplasmic (N-ter-NES/bGal) localization in QM7 avian myoblasts. Cell localization was assessed at cell con¯uence at the induction of dierentiation; per cent of cells with bGal in the nuclei was established in all bGal-expressing cells. Myoblast withdrawal from the cell cycle was assessed by determining the number of cells expressing connectin (a post-mitotic marker) at cell con¯uence. Results are expressed as per cent of the total number of counted nuclei. Myoblast dierentiation was assessed by calculation of the fusion index (FI) 48 h after serum removal (FI=Number of nuclei included in myotubes6100/total number of nuclei in the same micrpscopic ®eld). The per cent of post-mitotic cells and the fusion index were established by counting of all cells, independently on bGal staining, in order to take into account a possible paracrine in¯uence induced by changes in gene expression resulting from BTG1 presence in the nucleus. All data are presented as the mean+s.e.mean of seven independent experiments. **P50.001 with bGal expressing cells (Bogdan et al., 1998) . We found that: (i) the presence of the C-terminus besides to the B box induced nuclear retention of bGal and (ii) the disruption of the phosphorylation site by a glycine to serine 159 substitution signi®cantly inhibited this activity. This clearly suggests that the nuclear retention induced by the C-terminal is probably related to its phosphorylation-dependent ability to allow formation of a BTG1/CAF1 complex. In addition, Bogdan et al. (1998) have established that disruption of the BTG1 carboxy-terminal phosphorylation site not only inhibits the interaction of BTG1 with CAF1, but also its antiproliferative activity. All these data suggest that the T3 induced rise in BTG1 nuclear accumulation previously shown at cell con¯uence could play a major role in the increase of myoblast withdrawal rate from the cell cycle, and the resulting stimulation of terminal dierentiation (Marchal et al., 1995; Rodier et al., 1999) .
In addition to these sequences, we found that BTG1 displays an LxxLL-related sequence (LQELL, amino acids 44 ± 48). Such sequences, previously identi®ed in transcriptional coactivators, mediate their interaction with members of the nuclear receptor superfamily (Heery et al., 1997) . We found that this sequence was able to drive bGal to the nucleus, with reduced eciency relatively to the B box; in addition, deletion of this sequence clearly decreased the nuclear localization of the BTG1D1 ± 43/ûGal chimeric protein. These data raise the possibility that, by directly interacting with BTG1, some nuclear receptors could contribute to its nuclear import. In addition, as this import activity appears strongly decreased in the presence of a domain bearing two putative phosphorylation sites (Ser 33 and Ser43), this putative interaction could be under the control of post-transcriptional events. Therefore our data clearly raise the question of a possible interaction of BTG1 with nuclear receptors, and of its involvement in the physiological activity of the protein.
The nuclear export of BTG1 is mediated by a Nuclear Export Signal Besides the occurrence of an active import pathway, we demonstrated that a putative NES sequence encompassing the B box was indeed involved in BTG1 tracking. Not only the sequence of this motif exactly matched the characteristic leucine spacing reported in other NESs, but also we obtained direct experimental evidence of its functional activity. First, sensitivity to Leptomycin B, shown to disrupt functionality of NESs by altering their ability to interact with CRM1 (Wol et al., 1997; Kudo et al., 1998) , is considered as a major characteristic of these sequences. Interestingly, we showed that this antibiotic inhibited the nuclear eux of the endogenous BTG1 protein occurring during myoblast release in G1 after serum deprivation. Second, restoration of the NES sequence in a construct essentially detected in the nucleus (B-C-ter/bGal) strongly reduced the frequency of this exclusive localization, thus involving the motif in the export sensitivity to Leptomycin B. Altogether, our data clearly indicate that an atypical nuclear import motif (B box), a consensus NES, and interactions with nuclear proteins regulated by phosphorylation, are involved in nuclear BTG1 accumulation. However, we showed that other processes are involved in the cellular localization of the protein.
Two domains are involved in the cytoplasmic retention of BTG1
Further analysis of BTG1 led us to conclude that several sequences located in the amino-terminal domain of the protein were involved in a strong inhibition of BTG1 nuclear import. In particular, fusion of amino acids 1 ± 93 strongly reduced the nuclear localization of several chimeric proteins. In additional experiments, we found that two domains are essentially involved in the cytoplasmic retention of BTG1. A hydrophobic domain has been previously identi®ed in the ®rst 30 NH 2 -terminal amino acids of the protein. Interestingly, we found that, in the absence of a juxtaposed sequence displaying two putative phosphorylation sites (PP), addition of this domain induced an exclusive cytoplasmic localization of a chimeric protein initially detected in the nucleus of a majority of cells. However, this in¯uence was signi®cantly inhibited by the presence of the PP domain (2.5 decrease in the frequency of nuclear staining, D1 ± 30), thus raising the hypothesis that the ability of the NH 2 -terminus to maintain BTG1 in the cytoplasm could depend on phosphorylation of a downstream sequence. In addition, the involvement of a hydrophobic domain in BTG1 retention suggests a possible interaction with cell membranes, in agreement with previous cytoimmuno¯uorescence data obtained in mature myotubes (Rodier et al., 1999) .
Lastly, we also found that fusion of a sequence encompassing the well-conserved BTG A box led to a sevenfold decrease in the nuclear localization frequency of a chimeric protein (BTG1D1 ± 43/ûGal), thus underlining the functional importance of this sequence for the cytoplasmic retention of BTG1. As it has been previously shown that members of the BTG family could physically interact with cytoplasmic or membrane proteins, one possibility is that this sequence could mediate such interactions, thus both inducing alterations in some signalling pathways and preventing the occurrence of mechanisms triggered at the nuclear level.
Functional domains involved in BTG1 localization
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The nuclear localization is involved in the myogenic influence of BTG1
We have previously shown that BTG1 is at the brink of detection in proliferative myoblasts; it is essentially expressed at cell con¯uence in avian myoblasts, just before the induction of dierentiation. At this stage, it increases myoblast withdrawal from the cell cycle and stimulates consequently their terminal dierentiation (Rodier et al., 1999) . These data suggest that, in this cell type, BTG1 function is more related to the induction of the myogenic program than to an inhibition of proliferation. In addition, we found that BTG1 displays a major nuclear localization at cell con¯uence, signi®cantly increased by T3, which also stimulates myoblast withdrawal from the cell cycle and terminal dierentiation. Therefore, it was tempting to propose that BTG1 nuclear localization is strongly involved in the myogenic activity of this hormone. The present study well supports this hypothesis. First, we found that the B box and C-terminal domains of BTG1 are sucient to induce the myogenic in¯uence of BTG1; second, it appears that a BTG1 mutant devoid of these domains does not display any myogenic activity. Therefore, the B box and/or C-terminal domains of BTG1 have a key role in the stimulation of myoblast dierentiation. In addition, as this part of the protein includes a functional NLS and a nuclear retention domain, it is also strongly involved in the nuclear localization of BTG1. Over all our data demonstrate that: (i) a BTG1 mutant essentially located in the nucleus mimics the myogenic in¯uence of BTG1 and (ii) the domains involved in the nuclear localization of BTG1 are necessary and sucient to stimulate myoblast dierentiation. Therefore, they clearly suggest that BTG1 exerts its myogenic activity at the nuclear level, thus raising the question of its in¯uence upon gene expression through interactions with PRMT1, CAF1 or Hoxb9. The results indicating that mutation of serine 159, involved in the interaction with CAF1 (Bogdan et al., 1998) , abrogates the myogenic in¯uence of the Bbox-C-ter mutant clearly suggest that this component of the CCR4 transcriptional regulatory complex is involved in the BTG1 myogenic activity.
Conclusions
In this study, we brought evidence that BTG1 cellular localization is under a complex control mediated by several domains inducing nuclear import, export and retention, as well as cytoplasmic retention, as summarized in Figure 7 . In addition, presence of phosphorylation sites in sequences altering functionality of these BTG1 domains points out the occurrence of posttranslational regulatory events. Last, the present identi®cation of these sequences could help to ®nd new BTG1 partners, possibly nuclear receptors, involved in the physiological action of the protein.
In addition, related to previous data (Rodier et al., 1999) , it appears that BTG1, whose expression is induced at cell con¯uence in avian myoblasts, acts more as a myogenic inductor than as an antiproliferative protein in this cell type. Moreover, as the present study suggests that the nuclear localization of BTG1 is important for the myogenic in¯uence of the protein, we can hypothesize that BTG1 is probably involved in the stimulation of myoblast dierentiation induced by treatments potentiating its nuclear accumulation, as triiodothyronine, retinoic acid (unpublished data) or cAMP (Marchal et al., 1995) .
Materials and methods

Construction of DNA recombinant molecules
We constructed gene fusion with various parts of the human btg1 coding sequence fused to the 5' end of the E.coli Lac Z gene. The recombinant DNA molecules were generated using PCR with speci®c primers described below and inserted in the HindIII/KpnI sites of the pCH110 (Hall et al., 1983) vector, in frame with the bGal coding sequence. The parts of BTG1 ampli®ed, and the corresponding set of primers are summarized in Table 2 .
The LxxLL/bGal encoding vector was obtained by hybridizing the primers GCGAAGCTTGCCATGCTGCAG-GAGCTGCTGGTACCGCG and CGCGGTACCAGCAG-CTCTGCA GCATGGCAAGCTTCGC followed by HindIII/ KpnI digestion and ligation in the pCH110.
The BTG1D30 ± 43/bGal encoding vector was obtained by inserting a fragment encoding aa 1 ± 30 in the HindIII/KpnI sites of pCH110, followed by insertion of the fragment encoding aa 43 ± 171 in KpnI site. The BTG1DB/bGal was obtained by inserting a fragment encoding aa 1 ± 98 in HindIII/XbaI sites of the pCH 110 and a fragment encoding aa 117 ± 171 in XbaI/KpnI sites of the resulting vector.
Cell culture and transient transfections QM7, a previously established quail myoblast cell line (Antin and Ordahl, 1991) was cultured in M199 medium (Gibco, BRL) with 10% foetal bovine serum, tryptose phosphate 0.2%, L-glutamine 2 mM, gentamicin (50 mg/ml) and incubated at 378C under 5% CO 2 . For all experiments the cells were plated at a density of 7610 3 cells/cm 2 . In some experiments, cell synchronization in G0 was induced by a 24-h serum deprivation. Where indicated Leptomycin B (kindly provided by Dr B Wol-Winiski, Vienna, Austria) was added to the medium at a ®nal concentration of 10 ng/ml. For energy depletion, sodium azide (Sigma, St Louis, MO, USA) was used at a ®nal concentration of 10 mM, in the presence of cycloheximide 20 mg/ml and 6 mM 2-deoxyglucose.
DNA transfections were performed using calcium phosphate coprecipitation with a total of 2 mg of plasmid DNA as described previously (Wigler et al., 1978) . After 20 h, the DNA containing medium was replaced with fresh medium for a further 20 h.
Study of myoblast withdrawal from the cell cycle and terminal differentiation
Myoblast withdrawal from the cell cycle was assessed at cell con¯uence by counting of all cells expressing connectin, a post-mitotic marker. Connectin was detected by cytoimmuno¯uorescence using a ®rst antibody raised against the protein (Marchal et al., 1995) and a second¯uorescein conjugated raised against mouse immunoglobulins, as described below. The results are expressed as per cent of the total number of cells counted.
The extent of myoblast dierentiation was assessed by calculation of the fusion index (FI), 48 h after serum removal (FI=Number of nuclei included in myotubes6100/total number of nuclei counted in the same microscopic ®eld).
Immunofluorescence
For immunostaining of LacZ fusion proteins, QM7 cells were rinsed twice with room temperature PBS and ®xed at 7208C for 10 min in cold methanol. After two rinses in PBS and two in PBS containing 0.2% gelatin, a primary antibody raised against bGal (Gibco-BRL-Life technologies) diluted in PBS-0.2% gelatin was added and incubated for 45 min at 378C.
After two additional rinses in PBS and PBS-gelatin 0.2%, a second¯uorochrome conjugated antibody raised against Mouse IgG (Jackson Immunoresearch) diluted at 1/30 in PBS-0.2% gelatin was added and incubated for 45 min at 378C.
Immuno¯uorescent staining of endogenous BTG1 protein was carried out as previously described (Marchal et al., 1995) and analysed using a standard Zeiss Axiophot immuno¯uor-escence microscope.
The intracellular localization of the chimeric proteins was assessed by quanti®cation. Cells were counted according to the following localization features: (i) exclusive bGal nuclear staining (N), (ii) simultaneous nuclear and cytoplasmic staining (N/C) and (iii) exclusive bGal cytoplasmic staining (C). More than 100 bGal expressing cells were counted for each fusion protein in each experiment. In the ®rst part of the study, localization was studied in proliferative myoblasts. In experiments focused on the myogenic in¯uences of chimeric proteins, localization was assessed 24 h later, at cell con¯uence, at the induction of dierentiation.
Statistical analyses were performed using the paired t-test (Snedecor, 1961) . Functional domains involved in BTG1 localization A Rodier et al
